• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Convalescent Plasma: A Potential Life-Saving Therapy for Coronavirus Disease 2019 (COVID-19).

作者信息

Alghamdi Ahmed N, Abdel-Moneim Ahmed S

机构信息

Microbiology Department, College of Medicine, Taif University, Al-Taif, Saudi Arabia.

Virology Department, Faculty of Veterinary Medicine, Beni-Suef University, Beni Suef, Egypt.

出版信息

Front Public Health. 2020 Aug 6;8:437. doi: 10.3389/fpubh.2020.00437. eCollection 2020.

DOI:10.3389/fpubh.2020.00437
PMID:32903641
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7438749/
Abstract
摘要

相似文献

1
Convalescent Plasma: A Potential Life-Saving Therapy for Coronavirus Disease 2019 (COVID-19).康复期血浆：一种治疗2019冠状病毒病（COVID-19）的潜在救命疗法。
Front Public Health. 2020 Aug 6;8:437. doi: 10.3389/fpubh.2020.00437. eCollection 2020.
2
Convalescent plasma for COVID-19 considerations.关于新冠病毒病恢复期血浆的考量
Transfus Apher Sci. 2021 Feb;60(1):102927. doi: 10.1016/j.transci.2020.102927. Epub 2020 Aug 27.
3
Implications of Coronavirus Disease 2019 (COVID-19) Antibody Dynamics for Immunity and Convalescent Plasma Therapy.2019年冠状病毒病（COVID-19）抗体动力学对免疫及恢复期血浆治疗的影响
Clin Infect Dis. 2021 Aug 2;73(3):e540-e542. doi: 10.1093/cid/ciaa1213.
4
Impact of convalescent and nonimmune plasma on mortality of patients with COVID-19: a potential role for antithrombin.康复期血浆和非免疫血浆对COVID-19患者死亡率的影响：抗凝血酶的潜在作用。
Clin Microbiol Infect. 2021 Apr;27(4):637-638. doi: 10.1016/j.cmi.2020.09.007. Epub 2020 Sep 9.
5
High-Dose Convalescent Plasma for Treatment of Severe COVID-19 (response).高剂量恢复期血浆治疗重症新型冠状病毒肺炎（COVID-19）（回应）
Emerg Infect Dis. 2022 May;28(5):1083-1084. doi: 10.3201/eid2805.220363.
6
Covid-19 convalescent plasma and SARS-CoV-2 viral variants.新冠康复者血浆与严重急性呼吸综合征冠状病毒2病毒变体
Transfus Clin Biol. 2021 Aug;28(3):306. doi: 10.1016/j.tracli.2021.05.008. Epub 2021 May 29.
7
Use of Convalescent Plasma in the Management of COVID-19.康复期血浆在新型冠状病毒肺炎治疗中的应用
Mo Med. 2021 Mar-Apr;118(2):118.
8
COVID-19 convalescent plasma therapy and immunodeficiency.新冠康复者血浆疗法与免疫缺陷
Transfus Clin Biol. 2021 Aug;28(3):306-307. doi: 10.1016/j.tracli.2021.05.007. Epub 2021 May 29.
9
[Convalescent plasma therapy in COVID-19 patients].[新冠病毒肺炎患者的恢复期血浆治疗]
Medicina (B Aires). 2021;81(2):306.
10
High-titer convalescent plasma therapy for coronavirus disease 2019 and mortality.2019冠状病毒病的高滴度恢复期血浆疗法与死亡率
Transfusion. 2021 Jun;61(6):1988-1990. doi: 10.1111/trf.16434. Epub 2021 May 26.

引用本文的文献

1
COVID-19 Semantic Pneumonia Segmentation and Classification Using Artificial Intelligence.利用人工智能进行 COVID-19 语义肺炎分割和分类。
Contrast Media Mol Imaging. 2022 Sep 15;2022:5297709. doi: 10.1155/2022/5297709. eCollection 2022.
2
Long-Term Immunity and Antibody Response: Challenges for Developing Efficient COVID-19 Vaccines.长期免疫与抗体反应：开发高效新冠疫苗面临的挑战
Antibodies (Basel). 2022 May 12;11(2):35. doi: 10.3390/antib11020035.
3
Novel antiviral effects of chloroquine, hydroxychloroquine, and green tea catechins against SARS CoV-2 main protease (Mpro) and 3C-like protease for COVID-19 treatment.氯喹、羟氯喹和绿茶儿茶素对严重急性呼吸综合征冠状病毒2型主要蛋白酶（Mpro）和3C样蛋白酶的新型抗病毒作用用于治疗新型冠状病毒肺炎。
Clin Nutr Open Sci. 2022 Apr;42:62-72. doi: 10.1016/j.nutos.2021.12.004. Epub 2022 Jan 28.
4
Potential Adverse Effects of Dexamethasone Therapy on COVID-19 Patients: Review and Recommendations.地塞米松治疗对COVID-19患者的潜在不良影响：综述与建议
Infect Dis Ther. 2021 Dec;10(4):1907-1931. doi: 10.1007/s40121-021-00500-z. Epub 2021 Jul 22.
5
Novel coronavirus disease 2019 (COVID-19) pandemic: From transmission to control with an interdisciplinary vision.新型冠状病毒病 2019（COVID-19）大流行：从跨学科视角看传播与控制。
Environ Res. 2021 Jun;197:111126. doi: 10.1016/j.envres.2021.111126. Epub 2021 Apr 5.
6
Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis.恢复期血浆用于 COVID-19 的预防和治疗：系统评价和定量分析。
JMIR Public Health Surveill. 2021 Apr 7;7(4):e25500. doi: 10.2196/25500.
7
Insights into SARS-CoV-2 evolution, potential antivirals, and vaccines.SARS-CoV-2 进化、潜在抗病毒药物和疫苗的研究进展。
Virology. 2021 Jun;558:1-12. doi: 10.1016/j.virol.2021.02.007. Epub 2021 Feb 22.
8
The COVID-19 Treatment Landscape: A South African Perspective on a Race Against Time.新冠疫情治疗全景：南非视角下与时间的赛跑
Front Med (Lausanne). 2021 Feb 19;8:604087. doi: 10.3389/fmed.2021.604087. eCollection 2021.
9
An Insight Into COVID-19: A 21st Century Disaster and Its Relation to Immunocompetence and Food Antioxidants.深入了解新冠病毒：一场21世纪的灾难及其与免疫能力和食物抗氧化剂的关系。
Front Vet Sci. 2021 Jan 13;7:586637. doi: 10.3389/fvets.2020.586637. eCollection 2020.
10
COVID-19: Characteristics and Therapeutics.新型冠状病毒肺炎（COVID-19）：特征与治疗。
Cells. 2021 Jan 21;10(2):206. doi: 10.3390/cells10020206.

本文引用的文献

1
Treatment with convalescent plasma for COVID-19 patients in Wuhan, China.中国武汉 COVID-19 患者恢复期血浆治疗。
J Med Virol. 2020 Oct;92(10):1890-1901. doi: 10.1002/jmv.25882. Epub 2020 Jun 29.
2
Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea.韩国两名急性呼吸窘迫综合征 COVID-19 患者使用恢复期血浆疗法。
J Korean Med Sci. 2020 Apr 13;35(14):e149. doi: 10.3346/jkms.2020.35.e149.
3
Effectiveness of convalescent plasma therapy in severe COVID-19 patients.恢复期血浆疗法治疗重症 COVID-19 患者的疗效。
Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9490-9496. doi: 10.1073/pnas.2004168117. Epub 2020 Apr 6.
4
Treatment With Convalescent Plasma for Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.恢复期血浆治疗严重急性呼吸综合征冠状病毒 2 感染的危重症患者。
Chest. 2020 Jul;158(1):e9-e13. doi: 10.1016/j.chest.2020.03.039. Epub 2020 Mar 31.
5
Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how?采集和评估恢复期血浆用于 COVID-19 治疗：为什么以及如何？
Vox Sang. 2020 Aug;115(6):488-494. doi: 10.1111/vox.12926. Epub 2020 May 3.
6
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.5 例危重症 COVID-19 患者接受恢复期血浆治疗。
JAMA. 2020 Apr 28;323(16):1582-1589. doi: 10.1001/jama.2020.4783.
7
The convalescent sera option for containing COVID-19.使用康复期血清来控制新型冠状病毒肺炎。
J Clin Invest. 2020 Apr 1;130(4):1545-1548. doi: 10.1172/JCI138003.
8
Convalescent plasma as a potential therapy for COVID-19.康复期血浆作为治疗新冠肺炎的一种潜在疗法。
Lancet Infect Dis. 2020 Apr;20(4):398-400. doi: 10.1016/S1473-3099(20)30141-9. Epub 2020 Feb 27.
9
Potential interventions for novel coronavirus in China: A systematic review.中国新型冠状病毒潜在干预措施的系统评价。
J Med Virol. 2020 May;92(5):479-490. doi: 10.1002/jmv.25707. Epub 2020 Mar 3.
10
Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience.中东呼吸综合征冠状病毒感染中恢复期血浆输注治疗的挑战：单中心经验
Antivir Ther. 2018;23(7):617-622. doi: 10.3851/IMP3243. Epub 2018 Jun 20.